Ki-ras mutations in exocrine pancreatic cancer: Association with clinico-pathological characteristics and with tobacco and alcohol consumption

International Journal of Cancer

Volumn 70, Issue 6, 1997, Pages 661-667

  Malats, Núria ^a   Porta, Miquel ^a   Corominas, Josep M ^a   Piñol, Josep L ^a   Rifà, Juli ^b   Real, Francisco X ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; TOBACCO SMOKE;

ALCOHOL CONSUMPTION; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATION; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; ALCOHOL DRINKING; AMINO ACID SEQUENCE; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 0030963513     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970317)70:6<661::AID-IJC6>3.0.CO;2-T     Document Type: Article

References (42)

1. ALMOGUERA, C., SHIBATA, D., FORRESTER, K., MARTIN, J., ARNHEIM, N. and PERUCHO, M., Most human carcinomas of the exocrine pancreas contain mutant c-Ki-ras genes. Cell, 53, 549-554 (1988).
2. BERROZPE, G., SCHAEFFER, J., PEINADO, M.A., REAL, F.X. and PERUCHO, M., Comparative analysis of mutations in p53 and Ki-ras genes in pancreas cancer. Int. J. Cancer, 58, 185-191 (1994).
3. BOYLE, P., HSIEH, C.C., MAISONNEUVE, P., LA VECCHIA, C., MACFARLANE, G.J., WALKER, A.M. and TRICHOPOULOS, D., Epidemiology of pancreas cancer (1988). Int. J. Pancrealol, 5, 327-346 (1989).
4. BRENNAN, J.A., BOYLE, J.O., KOCH, W.M., GOODMAN, R.H., EBY, Y.J., COUCH, M.J., FORASTIERE, A.A. and SIDRANSKY, D., Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. New Engl. J. Med., 332, 712-717 (1995).
5. BUENO DE MESQUITA, H.B., MAISONNEUVE, P., MOERMAN, C.J., RUNIA, S. and BOYLE, P., Life-time history of smoking and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int. J. Cancer, 49, 816-822 (1991).
6. BUENO DE MESQUITA, H.B., MAISONNEUVE, P., MOERMAN, C.J., RUNIA, S. and BOYLE, P., Lifetime consumption of alcoholic beverages, tea and coffee and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int. J. Cancer, 50, 514-522 (1992).
7. CALDAS, C., HAHN, S.A., HRUBAN, R.H., REDSTON, M.S., YEO, C.J. and KERN, S.E., Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res., 54, 3568-3573 (1994).
8. CALDAS, C. and KERN, S.E., K-ras mutation and pancreatic adenocarcinoma. Int. J. Pancreatol, 18, 1-6 (1995).
9. CAPELLÀ, G., CRONAUER-MITRA, S., PEINADO, M.A. and PERUCHO, M., Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ. Hlth Perspect., 93, 125-131 (1991).
10. CARRIAGA, M.T. and HENSON, D.E., Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer, 75, 17 171s-190s (1995).
11. CHASSAGNE, P., DAUJAT, M., MAUREL, P., MICHEL, H. and LARREY, D., Cytochromes p-450 1A1 and 2E1 are present in human pancreas. Evidence by molecular biology. Gastroenterology, 108, A348 (1995).
12. FlNKELSTEIK, S.D., PRYGODZKI, R., PRICOLO, V.E., SAYEGH, R., BAKKER, A., SWALSKY, P.A. and KELLER, G., Ki-ras-2 topographic genotyping of pancreatic adenocarcinoma. Arch. Surg., 129, 367-372 (1994).
13. FOSTER, E.G., IDLE, J.R., HARDWICK, J.P., BARS, R., SCOTT, P. and BRAGANZA, J.M., Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J. Pathol., 169, 457-463 (1993).
14. FRANCESCHI, S., GLOGHINI, A., MAESTRO, R., BARZAN, L., BIDOLI, E., TALAMINI, R., VUKOSAVIJENIC, T., CARBONE, A. and BOIOCCHI, M., Analysis of the p53 sene in relation to tobacco and alcohol in cancers of the upper aero-digestive tract. Int. J. Cancer, 60, 872-876 (1995).
15. FUJJI, H., EGAMI, H., CHANEY, W., POUR, P. and PELLIG, J., Pancreatic ductal adenocarcinomas induced in Syriam hamsters by N-nitrosobis (2-oxopropyl) amine contain a c-Ki-ras oncogene with point-mutated codon 12. Mol. Carcinogen., 3, 296-301 (1990).
16. GRÜNEWALD, K., LYONS, J., FRÖHLICH, A., FEICHTINGER, H., WEGER, R.A., SCHWAB, G., JANSSEN, J.W.G. and BAETRAM, C.R., High frequency of Ki-ras codon-12 mutations in pancreatic adenocarcinomas. Int. J. Cancer, 43, 1037-1041 (1989).
17. HADDOCK, G. and CARTER, D.C., Aetiology of pancreatic cancer. Brit. J. Surg., 77, 1159-1166 (1990).
18. HOORENS, A., LEMOINE, N.R., MCLELLAN, E., MOROHOSHI, T., KAMTSAWA, T., HEITZ, P.U., STAMM, B., RUSCHOFF, J., WIEDENMANN, B. and KLOPPEL, G., Pancreatic acinar-cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Amer. J. Paihol., 143, 685-698 (1993).
19. HOWE, G.R., JAIN, M., BURCH, J.D. and MILLER, A.B., Cigarette smoking and cancer of the pancreas: evidence from a population-based case-control study in Toronto, Canada. Int. J. Cancer, 47, 323-328 (1991).
20. HRUBAN, R.H., VAN MANSFELD, A.D., OFEERHAUS, G.J., VAN WEERING, D.H., ALLISON, D.C. GOODMAN, S.N., KENSLER, T.W., BOSE, K.K., CAMERON, J.L. and BOS, J.L., Ki-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase-chain-reaction analysis and allele-specific oligonucleotide hybridization. Amer. J. Pathol, 143, 545-554 (1993).
21. HUSGAFVEL-PURSIAINEN, K., HACKMAN, P., RlNDANPÄÄ, M., ANTTILA, S., KARJALAINEN, A., PARTANEN,T., TAIKINA-AHO, O., HEIKKILA, L. andVAINIO, H., Ki-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Int. J. Cancer, 53, 250-256 (1993).
22. IGUCHI, H., SUGANO, K., FUKAYAMA, N., OHKURA, H., SADAMOTO, K., OHKOSHI, K., SEO, Y., TOMODA, H., FUNAKOSHI, A. and WAKASUGI, H., Analysis of Ki-ras codon-12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology, 110, 221-226 (1996).
23. LEE, E.Y., CIBULL, M.L., O'DANIEL-PEARCE, E., STRUDEL, W.E. and JENNINGS, C.D., Expression of p53 protein in pancreatic adenocarcinoma. Relationship to cigarette smoking. Int. J. Pancreatol., 17, 237-242 (1995).
24. MALATS, N., PORTA, M., PIÑOL, J.L., COROMINAS, J.M., RIFÀ, J. and REAL, F.X., FOR THE PANKRAS I PROJECT INVESTIGATORS, Ki-ras mutations as a prognostic factor in extra-hepatic-bile-system cancer. J. clin. Oncol., 13, 1679-1686 (1995).
25. MARIYAMA, M., KISHI, K., NAKAMURA, K., OBATA, H. and NISHIMURA, S., Frequency and types of point mutation at the 12th codon of the c-Ki-ras sene found in pancreatic cancers from Japanese patients. Jap. J. Cancer Res., 80, 622-626 (1989).
26. MOTOJIMA, K., URANO, T., NAGATA, Y., SHIKU, H., TSURIFUNE, T. and KANEMATSU, T., Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann. Surg., 217, 138-143 (1993).
27. NAGATA, Y., ABE, M., MOTOSHIMA, K., NAKAYAMA, E. and SHIKU, H., Frequent glycine-to-aspartic-acid mutations at codon 12 of c-Ki-ras in human pancreatic cancer in Japanese. Jap. J. Cancer Res., 81, 135-140 (1990).
28. PELLEGATA, N.S., SESSA, F., RENAULT, B., BONATO, M., LEONE, B.E., SOLCIA, E. and RANZANI, G.N., K-ras and p53 gene mutations in pancreatic cancer: duclal and non-ductal tumors progress through different genetic lesions. Cancer Res., 54, 1556-1560 (1994).
29. PORTA, M., MALATS, N., PINOL, J.L., RIFÀ. J., ANDREU, M. and REAL, F.X., FOR THE PANKRAS I PROJECT INVESTIGATORS, Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. J. clin. Epidemiol., 47, 1069-1079 (1994).
30. PORTA, M., MALATS, N., PTNOL, J.L., REAL, F.X. and RIFÀ, J., Relevance of misclassification of disease status in epidemiologic studies of exocrine pancreatic cancer. J. clin. Epidemiol., 49, 602-603 (1996).
31. SCARPA, A., CAPELLI, P., VILLANUEVA, A., ZAMBONI. G., LLUÍS, F., ACCOLA, R., MARIUZZI, G. and CAPELLÀ, G., Pancreatic cancer in Europe: Ki-ras-gene-mutation pattern shows geographical differences. Int. J. Cancer, 57, 167-171 (1994).
32. SCHAEFFER, B.K., GLASNER, S., KUHLMANN, E., MYLES, J.L. and LONGNECKER, D.S., Mutated c-K-ras in small pancreatic adenocarcinomas. Pancreas, 9, 161-165 (1994).
33. SHIBATA, D., ALMOGUERA, C., FORRESTER, K., DUNITZ, J., MARTIN, S.E., COSGROVE, M.M., PERUCHO, M. and ARNHEIM, N., Detection of c-K-ras mutations in fine-needle aspirates from human pancreatic adenocarcinomas. Cancer Res., 50, 1279-1283 (1990).
34. SILVERMAN, D.T. and 12 OTHERS, Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res., 55, 4899-4905 (1995).
35. TABATA, T., FUJIMORI, T., MAEDA, S., YAMAMOTO, M. and SAITOH, Y., The role of ras mutations in pancreatic cancer, pre-cancerous lesions and chronic pancreatitis. Int. J. Pancreatol., 14, 237-244 (1993).
36. TADA, M., OHASHI, M., SHIRATORI, Y., OKUDAIRA, T., KOMATSU, Y., KAWABE, T., YOSHIDA, H., MACHINAMI, R., KISHI, K. and OMATA, M., Analysis of K-ras gene mutations in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology, 110, 227-231 (1996).
37. TADA, M., YOKOSUKA, O., OMATA, M., OHTO, M., ISONO, K., Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer, 66, 930-935 (1990).
38. TAYLOR, J.A., SANDLER, D.P., BLOOMFIELD, C.D., SHORE, D.L., BALL, E.D., NEUBAUER, A., MCINTYRE, O.R. and LIU, E., ras oncogene activation and occupational exposures in acute myeloid leukemia. J. nat. Cancer Inst., 84, 1626-1632 (1992).
39. URRUTIA, R. and DIMAGNO, E.P., Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer? (Editorial) Gastroenterology, 110, 306-310 (1996).
40. WARSHAW, L.A. and FERNÁNDEZ DEL CASTILLO, C., Pancreatic carcinoma. New Engl. J. Med., 326, 455-465 (1992).
41. YANAGISAWA, A., OHASHI, K., HORI, M., TAKAGI, K., KITAGAWA, T., SUGANO, H. and KATO, Y., Ductectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: a novel clinicopathological entity. Jap. J. Cancer Res., 84, 474-479 (1993a).
42. YANAGISAWA, A., OHTAKE, K., OHASHI, K., HORI, M., KITAGAWA, T., SUGANO, H. and KATO, Y., Frequent c-Ki-ras oncogene activation in mucous-cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res., 53, 953-956 (1993b).